Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record now presents information about the Phase 2 nivolumab and ipilimumab study for classical Kaposi sarcoma, including its treatment plan, eligibility criteria, study location, and outcome measures.
    Difference
    44%
    Check dated 2026-11-09T13:20:29.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:57:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record itself remains unavailable.
    Difference
    1%
    Check dated 2026-10-26T14:25:28.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-19T14:10:32.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page remained a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-12T14:40:38.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A 403 error page now appears for the study entry, replacing the usual study information and indicating restricted access to the record.
    Difference
    17%
    Check dated 2026-09-21T22:13:54.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.